Drybench Patent.

Patent and exclusivity dates in 2031 for NDAs on FDA's Paragraph IV list, as FDA lists them

Each patent and exclusivity date in 2031 that FDA's Orange Book lists, as captured on 14 October 2026, for the 607 NDAs that FDA's Paragraph IV list names, as captured on 17 October 2026, and whose Orange Book capture lists a patent or exclusivity. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026
Paragraph IV list captured: 17 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers only NDAs that FDA's Paragraph IV list names and that have Orange Book listings. It does not cover other NDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

FDA's Paragraph IV list names no patent number, so it does not say which of the patents on this page an applicant certified against.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed patent expiry (415)

6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 8,291,904, product and use patent
patent.txt lines 199, 221
Flags
product use code U-1226
Product numbers
002, 003
6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 8,573,209, product patent
patent.txt lines 205, 227
Flags
product
Product numbers
002, 003
6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 8,573,210, product and use patent
patent.txt lines 207, 229
Flags
product use code U-1453
Product numbers
002, 003
6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 8,776,794, product and use patent
patent.txt lines 209, 231
Flags
product use code U-1226
Product numbers
002, 003
6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 8,776,795, product and use patent
patent.txt lines 211, 233
Flags
product use code U-1226
Product numbers
002, 003
6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 9,265,911, product and use patent
patent.txt line 239
Flags
product use code U-1824
Product numbers
003
6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 9,295,802, product and use patent
patent.txt line 243
Flags
product use code U-1226
Product numbers
003
6 Jan 2031 · NDA 020845 · NITRIC OXIDE
US 9,408,993, product and use patent
patent.txt line 245
Flags
product use code U-1824
Product numbers
003
10 Jan 2031 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 11,033,543, use patent
patent.txt line 2,202
Flags
use code U-1583
Product numbers
001
15 Jan 2031 · NDA 211675 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt line 13,015
Flags
substance use code U-3255
Product numbers
001
15 Jan 2031 · NDA 211675 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt line 13,016
Flags
substance use code U-3275
Product numbers
001
15 Jan 2031 · NDA 211675 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt line 13,018
Flags
substance use code U-3371
Product numbers
001
15 Jan 2031 · NDA 211675 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt line 13,020
Flags
substance use code U-3945
Product numbers
001
15 Jan 2031 · NDA 211675 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt line 13,021
Flags
substance use code U-3946
Product numbers
001
15 Jan 2031 · NDA 211675 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt lines 13,017, 13,046, 13,065
Flags
substance use code U-3341
Product numbers
001, 002, 003
15 Jan 2031 · NDA 211675 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt lines 13,019, 13,047, 13,066
Flags
substance use code U-3624
Product numbers
001, 002, 003
15 Jan 2031 · NDA 218347 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt line 20,976
Flags
substance use code U-3945
Product numbers
001
15 Jan 2031 · NDA 218347 · UPADACITINIB
US 8,962,629, substance and use patent
patent.txt line 20,977
Flags
substance use code U-3946
Product numbers
001
16 Jan 2031 · NDA 022192 · ILOPERIDONE
US 9,072,742, use patent
patent.txt lines 1,152, 1,166, 1,180, 1,194, 1,208, 1,222, 1,236
Flags
use code U-1674
Product numbers
001, 002, 003, 004, 005, 006, 007
20 Jan 2031 · NDA 022512 · DABIGATRAN ETEXILATE MESYLATE
US 9,034,822, use patent
patent.txt lines 2,016, 2,020, 2,024
Flags
use code U-1759
Product numbers
001, 002, 003
20 Jan 2031 · NDA 211728 · MITOMYCIN
US 12,268,745, use patent
patent.txt line 13,133
Flags
use code U-4172
Product numbers
001
20 Jan 2031 · NDA 211728 · MITOMYCIN
US 9,040,074, product patent
patent.txt line 13,134
Flags
product
Product numbers
001
20 Jan 2031 · NDA 211728 · MITOMYCIN
US 9,950,069, product patent
patent.txt line 13,135
Flags
product
Product numbers
001
22 Jan 2031 · NDA 203496 · TREPROSTINIL DIOLAMINE
US 8,349,892, product patent
patent.txt lines 3,948, 3,957, 3,966, 3,975, 3,984
Flags
product
Product numbers
001, 002, 003, 004, 005
24 Jan 2031 · NDA 210192 · DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US 10,426,780, substance and product and use patent
patent.txt line 11,204
Flags
substance product use code U-257
Product numbers
001
24 Jan 2031 · NDA 211994 · DOLUTEGRAVIR SODIUM; LAMIVUDINE
US 11,234,985, product and use patent
patent.txt line 13,375
Flags
product use code U-257
Product numbers
001
26 Jan 2031 · NDA 022264 · PALIPERIDONE PALMITATE
US 9,439,906, use patent
patent.txt lines 1,420, 1,422, 1,424, 1,426, 1,428
Flags
use code U-2757
Product numbers
001, 002, 003, 004, 005
26 Jan 2031 · NDA 022264 · PALIPERIDONE PALMITATE
US 9,439,906, use patent
patent.txt lines 1,421, 1,423, 1,425, 1,427, 1,429
Flags
use code U-2758
Product numbers
001, 002, 003, 004, 005
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 10,010,533, product patent
patent.txt line 5,663
Flags
product
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 11,103,483, product and use patent
patent.txt line 5,664
Flags
product use code U-1971
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 11,103,483, product and use patent
patent.txt line 5,665
Flags
product use code U-1972
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 11,844,783, use patent
patent.txt line 5,666
Flags
use code U-1542
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 11,844,783, use patent
patent.txt line 5,667
Flags
use code U-1971
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 11,844,783, use patent
patent.txt line 5,668
Flags
use code U-1972
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 11,872,214, product patent
patent.txt line 5,669
Flags
product
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 12,138,248, product patent
patent.txt line 5,670
Flags
product
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 12,350,257, product and use patent
patent.txt line 5,671
Flags
product use code U-1542
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 12,350,257, product and use patent
patent.txt line 5,672
Flags
product use code U-1971
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 12,350,257, product and use patent
patent.txt line 5,673
Flags
product use code U-1972
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 9,265,831, product patent
patent.txt line 5,678
Flags
product
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,796, product and use patent
patent.txt line 5,679
Flags
product use code U-1971
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,796, product and use patent
patent.txt line 5,680
Flags
product use code U-1972
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,797, use patent
patent.txt line 5,681
Flags
use code U-1971
Product numbers
001
28 Jan 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,797, use patent
patent.txt line 5,682
Flags
use code U-1972
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 10,010,533, product patent
patent.txt line 8,298
Flags
product
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 11,103,483, product and use patent
patent.txt line 8,301
Flags
product use code U-1971
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 11,103,483, product and use patent
patent.txt line 8,302
Flags
product use code U-1972
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 11,844,783, use patent
patent.txt line 8,303
Flags
use code U-1542
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 11,844,783, use patent
patent.txt line 8,304
Flags
use code U-1971
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 11,844,783, use patent
patent.txt line 8,305
Flags
use code U-1972
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 11,872,214, product patent
patent.txt line 8,306
Flags
product
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 12,138,248, product patent
patent.txt line 8,307
Flags
product
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 12,350,257, product and use patent
patent.txt line 8,308
Flags
product use code U-1542
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 12,350,257, product and use patent
patent.txt line 8,309
Flags
product use code U-1971
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 12,350,257, product and use patent
patent.txt line 8,310
Flags
product use code U-1972
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,265,831, product patent
patent.txt line 8,316
Flags
product
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,796, product and use patent
patent.txt line 8,317
Flags
product use code U-1971
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,796, product and use patent
patent.txt line 8,318
Flags
product use code U-1972
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,797, use patent
patent.txt line 8,319
Flags
use code U-1971
Product numbers
001
28 Jan 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 9,572,797, use patent
patent.txt line 8,320
Flags
use code U-1972
Product numbers
001
31 Jan 2031 · NDA 205494 · ELIGLUSTAT TARTRATE
US 10,888,547, use patent
patent.txt line 5,453
Flags
use code U-3042
Product numbers
001
31 Jan 2031 · NDA 205494 · ELIGLUSTAT TARTRATE
US 10,888,547, use patent
patent.txt line 5,454
Flags
use code U-3043
Product numbers
001
3 Feb 2031 · NDA 214487 · AVACOPAN
US 8,445,515, substance and product patent
patent.txt line 15,813
Flags
substance product
Product numbers
001
7 Feb 2031 · NDA 208325 · ETELCALCETIDE
US 8,999,932, substance and product and use patent
patent.txt lines 8,463, 8,471, 8,479
Flags
substance product use code U-2014
Product numbers
001, 002, 003
10 Feb 2031 · NDA 022192 · ILOPERIDONE
US 9,074,256, use patent
patent.txt lines 1,155, 1,169, 1,183, 1,197, 1,211, 1,225, 1,239
Flags
use code U-1674
Product numbers
001, 002, 003, 004, 005, 006, 007
10 Feb 2031 · NDA 200327 · CEFTAROLINE FOSAMIL
US 8,247,400, product and use patent
patent.txt lines 2,216, 2,218
Flags
product use code U-282
Product numbers
001, 002
15 Feb 2031 · NDA 202100 · METHYLPHENIDATE HYDROCHLORIDE
US 8,287,903, product patent
patent.txt line 2,750
Flags
product
Product numbers
001
15 Feb 2031 · NDA 202100 · METHYLPHENIDATE HYDROCHLORIDE
US 8,465,765, product and use patent
patent.txt line 2,751
Flags
product use code U-1415
Product numbers
001
15 Feb 2031 · NDA 202100 · METHYLPHENIDATE HYDROCHLORIDE
US 8,563,033, product and use patent
patent.txt line 2,752
Flags
product use code U-1415
Product numbers
001
15 Feb 2031 · NDA 202100 · METHYLPHENIDATE HYDROCHLORIDE
US 8,778,390, product and use patent
patent.txt line 2,753
Flags
product use code U-1543
Product numbers
001
15 Feb 2031 · NDA 202100 · METHYLPHENIDATE HYDROCHLORIDE
US 8,956,649, product and use patent
patent.txt line 2,754
Flags
product use code U-1665
Product numbers
001
15 Feb 2031 · NDA 202100 · METHYLPHENIDATE HYDROCHLORIDE
US 9,040,083, product patent
patent.txt line 2,755
Flags
product
Product numbers
001
15 Feb 2031 · NDA 207960 · METHYLPHENIDATE HYDROCHLORIDE
US 8,287,903, product patent
patent.txt lines 7,841, 7,851, 7,861
Flags
product
Product numbers
001, 002, 003
16 Feb 2031 · NDA 203085 · REGORAFENIB
US 8,637,553, substance and product patent
patent.txt line 3,605
Flags
substance product
Product numbers
001
17 Feb 2031 · NDA 202811 · LINACLOTIDE
US 8,933,030, product and use patent
patent.txt line 3,342
Flags
product use code U-4345
Product numbers
001
17 Feb 2031 · NDA 202811 · LINACLOTIDE
US 8,933,030, product patent
patent.txt line 3,356
Flags
product
Product numbers
002
17 Feb 2031 · NDA 202811 · LINACLOTIDE
US 8,933,030, product and use patent
patent.txt line 3,370
Flags
product use code U-1516
Product numbers
003
17 Feb 2031 · NDA 202811 · LINACLOTIDE
US 8,933,030, product and use patent
patent.txt line 3,371
Flags
product use code U-3644
Product numbers
003
17 Feb 2031 · NDA 202811 · LINACLOTIDE
US 8,933,030, product and use patent
patent.txt line 3,372
Flags
product use code U-4566
Product numbers
003
24 Feb 2031 · NDA 202155 · APIXABAN
US 9,326,945, product patent
patent.txt lines 2,788, 2,796, 2,800
Flags
product
Product numbers
001, 002, 003
25 Feb 2031 · NDA 021997 · ZOLPIDEM TARTRATE
US 9,265,720, use patent
patent.txt lines 896, 898
Flags
use code U-674
Product numbers
001, 002
25 Feb 2031 · NDA 050790 · CYCLOSPORINE
US 8,292,129, product patent
patent.txt line 2,140
Flags
product delist requested
Product numbers
002
2 Mar 2031 · NDA 204168 · LEVOMILNACIPRAN HYDROCHLORIDE
US 8,481,598, use patent
patent.txt lines 4,337, 4,340, 4,343, 4,346
Flags
use code U-839
Product numbers
001, 002, 003, 004
5 Mar 2031 · NDA 201280 · LINAGLIPTIN
US 8,853,156, product and use patent
patent.txt line 2,339
Flags
product use code U-1642
Product numbers
001
10 Mar 2031 · NDA 208271 · METHYLNALTREXONE BROMIDE
US 10,307,417, product patent
patent.txt line 8,428
Flags
product
Product numbers
001
10 Mar 2031 · NDA 208271 · METHYLNALTREXONE BROMIDE
US 10,376,505, product patent
patent.txt line 8,429
Flags
product
Product numbers
001
10 Mar 2031 · NDA 208271 · METHYLNALTREXONE BROMIDE
US 8,524,276, product patent
patent.txt line 8,431
Flags
product
Product numbers
001
10 Mar 2031 · NDA 208271 · METHYLNALTREXONE BROMIDE
US 8,956,651, product patent
patent.txt line 8,432
Flags
product
Product numbers
001
10 Mar 2031 · NDA 208271 · METHYLNALTREXONE BROMIDE
US 9,314,461, product patent
patent.txt line 8,434
Flags
product
Product numbers
001
13 Mar 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,415,355, substance and product patent
patent.txt line 9,699
Flags
substance product
Product numbers
001
13 Mar 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,415,355, substance and product patent
patent.txt line 11,044
Flags
substance product
Product numbers
001
25 Mar 2031 · NDA 204708 · BRIMONIDINE TARTRATE
US 8,513,247, product and use patent
patent.txt line 4,984
Flags
product use code U-1428
Product numbers
001
25 Mar 2031 · NDA 204708 · BRIMONIDINE TARTRATE
US 8,513,249, product and use patent
patent.txt line 4,985
Flags
product use code U-1428
Product numbers
001
25 Mar 2031 · NDA 204708 · BRIMONIDINE TARTRATE
US 9,861,631, use patent
patent.txt line 4,986
Flags
use code U-1428
Product numbers
001
25 Mar 2031 · NDA 204708 · BRIMONIDINE TARTRATE
US 9,861,632, use patent
patent.txt line 4,987
Flags
use code U-1428
Product numbers
001
26 Mar 2031 · NDA 022204 · OXYBUTYNIN CHLORIDE
US 8,920,392, use patent
patent.txt line 1,341
Flags
use code U-1644
Product numbers
001
27 Mar 2031 · NDA 214876 · NIRAPARIB TOSYLATE
US 8,071,623, substance and product patent
patent.txt lines 16,278, 16,287, 16,296
Flags
substance product
Product numbers
001, 002, 003
29 Mar 2031 · NDA 203923 · SODIUM THIOSULFATE
US 8,496,973, substance and product and use patent
patent.txt line 4,184
Flags
substance product use code U-1419
Product numbers
001
3 Apr 2031 · NDA 208082 · DEUTETRABENAZINE
US 8,524,733, substance and product patent
patent.txt lines 8,133, 8,165, 8,197
Flags
substance product
Product numbers
001, 002, 003
3 Apr 2031 · NDA 216354 · DEUTETRABENAZINE
US 8,524,733, substance and product patent
patent.txt lines 18,550, 18,580, 18,610, 18,640, 18,670, 18,700, 18,730, 18,760
Flags
substance product
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
8 Apr 2031 · NDA 203085 · REGORAFENIB
US 9,458,107, product patent
patent.txt line 3,607
Flags
product
Product numbers
001
11 Apr 2031 · NDA 209241 · VALBENAZINE TOSYLATE
US 8,039,627, substance and product patent
patent.txt lines 9,952, 9,985, 10,018
Flags
substance product
Product numbers
001, 002, 003
11 Apr 2031 · NDA 218390 · VALBENAZINE TOSYLATE
US 8,039,627, substance and product patent
patent.txt lines 21,010, 21,043, 21,076
Flags
substance product
Product numbers
001, 002, 003
28 Apr 2031 · NDA 208743 · ABALOPARATIDE
US 7,803,770, use patent
patent.txt line 9,297
Flags
use code U-2009
Product numbers
001
28 Apr 2031 · NDA 208743 · ABALOPARATIDE
US RE49444, use patent
patent.txt line 9,301
Flags
use code U-2009
Product numbers
001
28 Apr 2031 · NDA 208743 · ABALOPARATIDE
US RE49444, use patent
patent.txt line 9,302
Flags
use code U-3543
Product numbers
001
28 Apr 2031 · NDA 212018 · ERDAFITINIB
US 9,464,071, use patent
patent.txt lines 13,398, 13,416, 13,434
Flags
use code U-3805
Product numbers
001, 002, 003
5 May 2031 · NDA 210854 · BALOXAVIR MARBOXIL
US 8,927,710, product patent
patent.txt lines 12,190, 12,201, 12,212
Flags
product
Product numbers
001, 002, 003
10 May 2031 · NDA 207962 · LIDOCAINE
US 10,765,640, product patent
patent.txt line 7,866
Flags
product
Product numbers
001
10 May 2031 · NDA 207962 · LIDOCAINE
US 10,765,749, product patent
patent.txt line 7,867
Flags
product
Product numbers
001
10 May 2031 · NDA 207962 · LIDOCAINE
US 11,278,623, product patent
patent.txt line 7,868
Flags
product
Product numbers
001
10 May 2031 · NDA 207962 · LIDOCAINE
US 11,786,455, product and use patent
patent.txt line 7,869
Flags
product use code U-2267
Product numbers
001
10 May 2031 · NDA 207962 · LIDOCAINE
US 11,793,766, use patent
patent.txt line 7,870
Flags
use code U-2267
Product numbers
001
10 May 2031 · NDA 207962 · LIDOCAINE
US 9,283,174, product patent
patent.txt line 7,871
Flags
product
Product numbers
001
10 May 2031 · NDA 207962 · LIDOCAINE
US 9,925,264, product and use patent
patent.txt line 7,872
Flags
product use code U-2267
Product numbers
001
10 May 2031 · NDA 207962 · LIDOCAINE
US 9,931,403, product patent
patent.txt line 7,873
Flags
product
Product numbers
001
12 May 2031 · NDA 050444 · MINOCYCLINE HYDROCHLORIDE
US 12,161,656, product patent
patent.txt line 2,137
Flags
product
Product numbers
001
12 May 2031 · NDA 050444 · MINOCYCLINE HYDROCHLORIDE
US 9,084,802, use patent
patent.txt line 2,138
Flags
use code U-282
Product numbers
001
12 May 2031 · NDA 050444 · MINOCYCLINE HYDROCHLORIDE
US 9,278,105, use patent
patent.txt line 2,139
Flags
use code U-282
Product numbers
001
18 May 2031 · NDA 020911 · BECLOMETHASONE DIPROPIONATE
US 9,463,289, product patent
patent.txt lines 379, 381
Flags
product delist requested
Product numbers
001, 002
18 May 2031 · NDA 020911 · BECLOMETHASONE DIPROPIONATE
US 9,808,587, product patent
patent.txt lines 380, 382
Flags
product delist requested
Product numbers
001, 002
18 May 2031 · NDA 207921 · BECLOMETHASONE DIPROPIONATE
US 10,022,509, product patent
patent.txt lines 7,440, 7,455
Flags
product delist requested
Product numbers
001, 002
18 May 2031 · NDA 207921 · BECLOMETHASONE DIPROPIONATE
US 10,022,510, product patent
patent.txt lines 7,441, 7,456
Flags
product delist requested
Product numbers
001, 002
18 May 2031 · NDA 207921 · BECLOMETHASONE DIPROPIONATE
US 10,086,156, product patent
patent.txt lines 7,442, 7,457
Flags
product delist requested
Product numbers
001, 002
18 May 2031 · NDA 207921 · BECLOMETHASONE DIPROPIONATE
US 10,695,512, product patent
patent.txt lines 7,444, 7,459
Flags
product delist requested
Product numbers
001, 002
18 May 2031 · NDA 207921 · BECLOMETHASONE DIPROPIONATE
US 11,395,889, product patent
patent.txt lines 7,447, 7,462
Flags
product delist requested
Product numbers
001, 002
18 May 2031 · NDA 209529 · SOLIFENACIN SUCCINATE
US 9,918,970, product patent
patent.txt line 10,604
Flags
product
Product numbers
001
19 May 2031 · NDA 214377 · VERICIGUAT
US 10,736,896, substance and product patent
patent.txt lines 15,736, 15,742, 15,748
Flags
substance product
Product numbers
001, 002, 003
19 May 2031 · NDA 214377 · VERICIGUAT
US 11,439,642, use patent
patent.txt lines 15,737, 15,743, 15,749
Flags
use code U-3062
Product numbers
001, 002, 003
19 May 2031 · NDA 214377 · VERICIGUAT
US 8,420,656, substance and product patent
patent.txt lines 15,738, 15,744, 15,750
Flags
substance product
Product numbers
001, 002, 003
19 May 2031 · NDA 214377 · VERICIGUAT
US 8,921,377, use patent
patent.txt lines 15,739, 15,745, 15,751
Flags
use code U-3062
Product numbers
001, 002, 003
19 May 2031 · NDA 214377 · VERICIGUAT
US 9,993,476, use patent
patent.txt lines 15,741, 15,747, 15,753
Flags
use code U-3062
Product numbers
001, 002, 003
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 10,758,543, product patent
patent.txt line 16,738
Flags
product
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 10,869,870, use patent
patent.txt line 16,740
Flags
use code U-3229
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 10,869,870, use patent
patent.txt line 16,741
Flags
use code U-3404
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,219,624, product and use patent
patent.txt line 16,743
Flags
product use code U-3229
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,571,425, product patent
patent.txt line 16,745
Flags
product
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,590,136, use patent
patent.txt line 16,746
Flags
use code U-3229
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,590,136, use patent
patent.txt line 16,747
Flags
use code U-3404
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 12,226,419, product patent
patent.txt line 16,751
Flags
product
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 12,544,381, product patent
patent.txt line 16,753
Flags
product
Product numbers
001
20 May 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 12,564,593, product patent
patent.txt line 16,754
Flags
product
Product numbers
001
23 May 2031 · NDA 200603 · LURASIDONE HYDROCHLORIDE
US 9,259,423, use patent
patent.txt lines 2,250, 2,261, 2,272, 2,283, 2,294
Flags
use code U-1822
Product numbers
001, 002, 003, 004, 005
23 May 2031 · NDA 200603 · LURASIDONE HYDROCHLORIDE
US 9,827,242, use patent
patent.txt lines 2,252, 2,263, 2,274, 2,285, 2,296
Flags
use code U-2199
Product numbers
001, 002, 003, 004, 005
23 May 2031 · NDA 200603 · LURASIDONE HYDROCHLORIDE
US 9,827,242, use patent
patent.txt lines 2,253, 2,264, 2,275, 2,286, 2,297
Flags
use code U-2201
Product numbers
001, 002, 003, 004, 005
26 May 2031 · NDA 214662 · MARALIXIBAT CHLORIDE
US 11,260,053, use patent
patent.txt line 15,925
Flags
use code U-3290
Product numbers
001
26 May 2031 · NDA 214662 · MARALIXIBAT CHLORIDE
US 11,260,053, use patent
patent.txt line 15,926
Flags
use code U-3974
Product numbers
001
26 May 2031 · NDA 219485 · MARALIXIBAT CHLORIDE
US 11,260,053, use patent
patent.txt lines 21,750, 21,759, 21,768, 21,777
Flags
use code U-4187
Product numbers
001, 002, 003, 004
29 May 2031 · NDA 208434 · ALECTINIB HYDROCHLORIDE
US 9,126,931, substance patent
patent.txt line 8,618
Flags
substance
Product numbers
001
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 5,468, 5,567
Flags
use code U-1684
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 5,469, 5,568
Flags
use code U-1946
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 5,470, 5,569
Flags
use code U-2241
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 5,471, 5,570
Flags
use code U-2242
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,016,435, use patent
patent.txt lines 5,473, 5,572
Flags
use code U-1650
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 5,485, 5,584
Flags
use code U-1650
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 5,486, 5,585
Flags
use code U-1684
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 5,487, 5,586
Flags
use code U-1946
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 5,488, 5,587
Flags
use code U-2241
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 5,489, 5,588
Flags
use code U-2242
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 5,490, 5,589
Flags
use code U-2665
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 5,491, 5,590
Flags
use code U-3422
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 5,495, 5,594
Flags
use code U-1491
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 5,496, 5,595
Flags
use code U-1946
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 5,497, 5,596
Flags
use code U-2943
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 5,498, 5,597
Flags
use code U-2944
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 5,503, 5,600
Flags
use code U-1684
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 5,504, 5,601
Flags
use code U-1946
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 5,505, 5,602
Flags
use code U-2241
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 5,506, 5,603
Flags
use code U-2242
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 8,999,999, use patent
patent.txt line 5,541
Flags
use code U-1683
Product numbers
001
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 8,999,999, use patent
patent.txt line 5,542
Flags
use code U-1684
Product numbers
001
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 8,999,999, use patent
patent.txt line 5,638
Flags
use code U-1491
Product numbers
002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 8,999,999, use patent
patent.txt line 5,639
Flags
use code U-1946
Product numbers
002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 8,999,999, use patent
patent.txt line 5,640
Flags
use code U-2228
Product numbers
002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 9,125,889, use patent
patent.txt line 5,544
Flags
use code U-1745
Product numbers
001
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 9,125,889, use patent
patent.txt line 5,642
Flags
use code U-1650
Product numbers
002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 9,801,881, use patent
patent.txt lines 5,563, 5,660
Flags
use code U-1491
Product numbers
001, 002
3 Jun 2031 · NDA 205552 · IBRUTINIB
US 9,801,883, use patent
patent.txt lines 5,565, 5,662
Flags
use code U-2159
Product numbers
001, 002
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 11,588, 11,694, 11,798, 11,902
Flags
use code U-1684
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 11,589, 11,695, 11,799, 11,903
Flags
use code U-1946
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 11,590, 11,696, 11,800, 11,904
Flags
use code U-2241
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,004,746, use patent
patent.txt lines 11,591, 11,697, 11,801, 11,905
Flags
use code U-2242
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,016,435, use patent
patent.txt lines 11,595, 11,701, 11,805, 11,909
Flags
use code U-1650
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 11,611, 11,717, 11,821
Flags
use code U-3422
Product numbers
001, 002, 003
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 11,605, 11,711, 11,815, 11,920
Flags
use code U-1650
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 11,606, 11,712, 11,816, 11,921
Flags
use code U-1684
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 11,607, 11,713, 11,817, 11,922
Flags
use code U-1946
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 11,608, 11,714, 11,818, 11,924
Flags
use code U-2241
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 11,609, 11,715, 11,819, 11,925
Flags
use code U-2242
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt lines 11,610, 11,716, 11,820, 11,926
Flags
use code U-2665
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt line 11,919
Flags
use code U-1456
Product numbers
004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,478,439, use patent
patent.txt line 11,923
Flags
use code U-1947
Product numbers
004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,653,696, use patent
patent.txt line 11,928
Flags
use code U-1456
Product numbers
004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 11,615, 11,721, 11,825, 11,932
Flags
use code U-1491
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 11,616, 11,722, 11,826, 11,933
Flags
use code U-1946
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 11,617, 11,723, 11,827, 11,934
Flags
use code U-2943
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 10,751,342, use patent
patent.txt lines 11,618, 11,724, 11,828, 11,935
Flags
use code U-2944
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 11,625, 11,729, 11,833
Flags
use code U-1684
Product numbers
001, 002, 003
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 11,626, 11,730, 11,834
Flags
use code U-1946
Product numbers
001, 002, 003
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 11,627, 11,731, 11,835
Flags
use code U-2241
Product numbers
001, 002, 003
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 11,672,803, use patent
patent.txt lines 11,628, 11,732, 11,836
Flags
use code U-2242
Product numbers
001, 002, 003
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 8,754,090, use patent
patent.txt line 11,972
Flags
use code U-1456
Product numbers
004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 8,999,999, use patent
patent.txt lines 11,669, 11,773, 11,877, 11,986
Flags
use code U-1491
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 8,999,999, use patent
patent.txt lines 11,670, 11,774, 11,878, 11,987
Flags
use code U-1946
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 8,999,999, use patent
patent.txt lines 11,671, 11,775, 11,879, 11,988
Flags
use code U-2241
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 8,999,999, use patent
patent.txt lines 11,672, 11,776, 11,880, 11,989
Flags
use code U-2242
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 9,125,889, use patent
patent.txt lines 11,674, 11,778, 11,882, 11,991
Flags
use code U-1650
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 9,801,881, use patent
patent.txt lines 11,688, 11,792, 11,896, 12,004
Flags
use code U-1491
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 9,801,881, use patent
patent.txt lines 11,689, 11,793, 11,897, 12,005
Flags
use code U-2242
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 9,801,883, use patent
patent.txt lines 11,691, 11,795, 11,899, 12,007
Flags
use code U-2159
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 9,801,883, use patent
patent.txt lines 11,692, 11,796, 11,900, 12,008
Flags
use code U-2243
Product numbers
001, 002, 003, 004
3 Jun 2031 · NDA 210563 · IBRUTINIB
US 9,814,721, use patent
patent.txt line 12,010
Flags
use code U-1947
Product numbers
004
5 Jun 2031 · NDA 213591 · CAPMATINIB HYDROCHLORIDE
US 8,420,645, substance and product patent
patent.txt lines 15,142, 15,149
Flags
substance product
Product numbers
001, 002
7 Jun 2031 · NDA 021035 · LEVETIRACETAM
US 8,802,142, product patent
patent.txt lines 400, 402, 404, 406
Flags
product
Product numbers
001, 002, 003, 004
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,130,640, product patent
patent.txt line 7,365
Flags
product
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,617,698, product patent
patent.txt line 7,366
Flags
product
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,660,908, product and use patent
patent.txt line 7,367
Flags
product use code U-2627
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,682,364, product patent
patent.txt line 7,368
Flags
product
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,688,108, use patent
patent.txt line 7,369
Flags
use code U-2627
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,716,799, product patent
patent.txt line 7,370
Flags
product
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 9,119,781, product and use patent
patent.txt line 7,372
Flags
product use code U-1761
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 9,119,781, product and use patent
patent.txt line 7,373
Flags
product use code U-2627
Product numbers
001
10 Jun 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 9,566,286, product patent
patent.txt line 7,374
Flags
product
Product numbers
001
11 Jun 2031 · NDA 211230 · SOLRIAMFETOL HYDROCHLORIDE
US 8,440,715, use patent
patent.txt lines 12,596, 12,635
Flags
use code U-2548
Product numbers
001, 002
13 Jun 2031 · NDA 204708 · BRIMONIDINE TARTRATE
US 10,201,517, product patent
patent.txt line 4,981
Flags
product
Product numbers
001
13 Jun 2031 · NDA 204708 · BRIMONIDINE TARTRATE
US 8,053,427, product and use patent
patent.txt line 4,982
Flags
product use code U-1428
Product numbers
001
13 Jun 2031 · NDA 204708 · BRIMONIDINE TARTRATE
US 8,163,725, product patent
patent.txt line 4,983
Flags
product
Product numbers
001
21 Jun 2031 · NDA 204026 · POMALIDOMIDE
US 8,828,427, substance and product patent
patent.txt lines 4,199, 4,205, 4,211, 4,217
Flags
substance product
Product numbers
001, 002, 003, 004
23 Jun 2031 · NDA 022205 · BALSALAZIDE DISODIUM
US 8,497,256, use patent
patent.txt line 1,345
Flags
use code U-1229
Product numbers
001
24 Jun 2031 · NDA 205596 · POSACONAZOLE
US 9,358,297, product and use patent
patent.txt line 5,690
Flags
product use code U-3160
Product numbers
001
24 Jun 2031 · NDA 205596 · POSACONAZOLE
US 9,358,297, product and use patent
patent.txt line 5,691
Flags
product use code U-3171
Product numbers
001
24 Jun 2031 · NDA 205596 · POSACONAZOLE
US 9,358,297, product and use patent
patent.txt line 5,692
Flags
product use code U-4415
Product numbers
001
24 Jun 2031 · NDA 205596 · POSACONAZOLE
US 9,358,297, product and use patent
patent.txt line 5,693
Flags
product use code U-4416
Product numbers
001
27 Jun 2031 · NDA 208573 · VENETOCLAX
US 8,546,399, substance and product patent
patent.txt lines 8,867, 8,881, 8,895
Flags
substance product
Product numbers
001, 002, 003
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 10,179,140, use patent
patent.txt line 12,841
Flags
use code U-2553
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 10,603,281, use patent
patent.txt line 12,842
Flags
use code U-2553
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 10,849,857, product and use patent
patent.txt line 12,843
Flags
product use code U-2553
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 10,987,364, product patent
patent.txt line 12,844
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,123,299, product patent
patent.txt line 12,845
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,291,632, product patent
patent.txt line 12,846
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,291,633, product patent
patent.txt line 12,847
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,351,122, product patent
patent.txt line 12,848
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,413,249, use patent
patent.txt line 12,849
Flags
use code U-2553
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,478,487, product patent
patent.txt line 12,850
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,504,334, product patent
patent.txt line 12,851
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 11,951,213, use patent
patent.txt line 12,852
Flags
use code U-2553
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 12,090,231, use patent
patent.txt line 12,853
Flags
use code U-2553
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 12,280,151, product patent
patent.txt line 12,854
Flags
product
Product numbers
001
28 Jun 2031 · NDA 211367 · DROSPIRENONE
US 9,603,860, use patent
patent.txt line 12,855
Flags
use code U-2553
Product numbers
001
30 Jun 2031 · NDA 022425 · DRONEDARONE HYDROCHLORIDE
US 8,602,215, use patent
patent.txt line 1,877
Flags
use code U-1473
Product numbers
001
30 Jun 2031 · NDA 204447 · VORTIOXETINE HYDROBROMIDE
US 8,722,684, substance and product patent
patent.txt lines 4,701, 4,721, 4,741, 4,761
Flags
substance product
Product numbers
001, 002, 003, 004
1 Jul 2031 · NDA 202331 · AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
US 9,387,249, use patent
patent.txt lines 3,067, 3,070
Flags
use code U-3
Product numbers
001, 002
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,685
Flags
product use code U-1698
Product numbers
001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,686
Flags
product use code U-3160
Product numbers
001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,687
Flags
product use code U-3171
Product numbers
001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,688
Flags
product use code U-4415
Product numbers
001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,689
Flags
product use code U-4416
Product numbers
001
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt lines 11,506, 11,529
Flags
use code U-2336
Product numbers
001, 002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,530
Flags
use code U-2802
Product numbers
002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,531
Flags
use code U-2803
Product numbers
002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,532
Flags
use code U-3738
Product numbers
002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,533
Flags
use code U-4051
Product numbers
002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,534
Flags
use code U-4440
Product numbers
002
4 Jul 2031 · NDA 210498 · BINIMETINIB
US 9,314,464, use patent
patent.txt line 11,553
Flags
use code U-2332
Product numbers
001
4 Jul 2031 · NDA 210498 · BINIMETINIB
US 9,314,464, use patent
patent.txt line 11,554
Flags
use code U-3737
Product numbers
001
17 Jul 2031 · NDA 207921 · BECLOMETHASONE DIPROPIONATE
US 8,931,476, product patent
patent.txt lines 7,454, 7,471
Flags
product
Product numbers
001, 002
18 Jul 2031 · NDA 208051 · NERATINIB MALEATE
US 8,669,273, use patent
patent.txt line 8,021
Flags
use code U-3047
Product numbers
001
18 Jul 2031 · NDA 208692 · CABOZANTINIB S-MALATE
US 10,034,873, use patent
patent.txt lines 9,177, 9,197, 9,217
Flags
use code U-2488
Product numbers
001, 002, 003
18 Jul 2031 · NDA 208692 · CABOZANTINIB S-MALATE
US 10,039,757, use patent
patent.txt lines 9,178, 9,198, 9,218
Flags
use code U-1480
Product numbers
001, 002, 003
18 Jul 2031 · NDA 209360 · ANGIOTENSIN II ACETATE
US 9,572,856, use patent
patent.txt lines 10,190, 10,220
Flags
use code U-2221
Product numbers
001, 003
19 Jul 2031 · NDA 211527 · TRIFAROTENE
US 7,807,708, substance and product patent
patent.txt line 12,879
Flags
substance product
Product numbers
001
21 Jul 2031 · NDA 021539 · ACETYLCYSTEINE
US 9,327,028, use patent
patent.txt line 630
Flags
use code U-1839
Product numbers
001
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,720, 8,777
Flags
use code U-2101
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,721, 8,778
Flags
use code U-2103
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,722, 8,779
Flags
use code U-2480
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,723, 8,780
Flags
use code U-2482
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,724, 8,781
Flags
use code U-2483
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,725, 8,782
Flags
use code U-2716
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,726, 8,783
Flags
use code U-2819
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,727, 8,784
Flags
use code U-2820
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,728, 8,785
Flags
use code U-2821
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,729, 8,786
Flags
use code U-2822
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,730, 8,787
Flags
use code U-2823
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,731, 8,788
Flags
use code U-2824
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,732, 8,789
Flags
use code U-2832
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,733, 8,790
Flags
use code U-2833
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,734, 8,791
Flags
use code U-3333
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,735, 8,792
Flags
use code U-3631
Product numbers
001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,736, 8,793
Flags
use code U-3695
Product numbers
001, 002
4 Aug 2031 · NDA 214876 · NIRAPARIB TOSYLATE
US 8,859,562, use patent
patent.txt lines 16,281, 16,290, 16,299
Flags
use code U-2655
Product numbers
001, 002, 003
6 Aug 2031 · NDA 214047 · LEVOTHYROXINE SODIUM
US 9,050,307, product patent
patent.txt line 15,461
Flags
product
Product numbers
001
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,675,325, product patent
patent.txt line 3,360
Flags
product
Product numbers
003
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,702,576, use patent
patent.txt line 3,362
Flags
use code U-1516
Product numbers
003
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,702,576, use patent
patent.txt line 3,363
Flags
use code U-3644
Product numbers
003
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,702,576, use patent
patent.txt line 3,364
Flags
use code U-4566
Product numbers
003
11 Aug 2031 · NDA 203496 · TREPROSTINIL DIOLAMINE
US 8,747,897, product and use patent
patent.txt lines 3,950, 3,960, 3,969, 3,978, 3,986
Flags
product use code U-2724
Product numbers
001, 002, 003, 004, 005
11 Aug 2031 · NDA 203496 · TREPROSTINIL DIOLAMINE
US 8,747,897, product and use patent
patent.txt lines 3,951, 3,961, 3,970, 3,979, 3,987
Flags
product use code U-2725
Product numbers
001, 002, 003, 004, 005
11 Aug 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 8,609,707, product and use patent
patent.txt line 5,674
Flags
product use code U-1971
Product numbers
001
11 Aug 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 8,609,707, product and use patent
patent.txt line 5,675
Flags
product use code U-1972
Product numbers
001
11 Aug 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 8,609,707, product and use patent
patent.txt line 8,311
Flags
product use code U-1542
Product numbers
001
12 Aug 2031 · NDA 206494 · AVIBACTAM SODIUM; CEFTAZIDIME
US 8,471,025, substance patent
patent.txt line 6,578
Flags
substance
Product numbers
001
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,716,785, use patent
patent.txt lines 14,886, 14,907, 14,928, 14,949
Flags
use code U-3136
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,716,785, use patent
patent.txt lines 14,887, 14,908, 14,929, 14,950
Flags
use code U-3137
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,185,541, use patent
patent.txt lines 14,888, 14,909, 14,930, 14,951
Flags
use code U-3140
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,241,425, use patent
patent.txt lines 14,889, 14,910, 14,931, 14,952
Flags
use code U-3137
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,351,166, use patent
patent.txt lines 14,890, 14,911, 14,932, 14,953
Flags
use code U-3140
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,351,166, use patent
patent.txt lines 14,891, 14,912, 14,933, 14,954
Flags
use code U-3141
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,793,805, use patent
patent.txt lines 14,893, 14,914, 14,935, 14,956
Flags
use code U-3734
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 12,194,035, use patent
patent.txt lines 14,896, 14,917, 14,938, 14,959
Flags
use code U-3141
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,126,977, product and use patent
patent.txt lines 14,901, 14,922, 14,943, 14,964
Flags
product use code U-3136
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,126,977, product and use patent
patent.txt lines 14,902, 14,923, 14,944, 14,965
Flags
product use code U-3137
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,517,235, use patent
patent.txt lines 14,903, 14,924, 14,945, 14,966
Flags
use code U-3138
Product numbers
001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,517,235, use patent
patent.txt lines 14,904, 14,925, 14,946, 14,967
Flags
use code U-3139
Product numbers
001, 002, 003, 004
25 Aug 2031 · NDA 210598 · REVEFENACIN
US 8,541,451, substance patent
patent.txt line 12,045
Flags
substance
Product numbers
001
26 Aug 2031 · NDA 213433 · CLASCOTERONE
US 9,433,628, substance and product patent
patent.txt line 15,011
Flags
substance product
Product numbers
001
30 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,119,848, substance patent
patent.txt lines 14,900, 14,921, 14,942, 14,963
Flags
substance
Product numbers
001, 002, 003, 004
4 Sep 2031 · NDA 209299 · FOSTAMATINIB DISODIUM
US 7,449,458, substance patent
patent.txt lines 10,038, 10,052
Flags
substance
Product numbers
001, 002
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 10,307,375, product patent
patent.txt line 4,107
Flags
product
Product numbers
001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 10,660,858, product patent
patent.txt line 4,108
Flags
product
Product numbers
001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 8,895,064, product patent
patent.txt line 4,109
Flags
product
Product numbers
001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 9,132,093, product patent
patent.txt line 4,110
Flags
product
Product numbers
001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 9,192,581, product and use patent
patent.txt line 4,111
Flags
product use code U-1325
Product numbers
001
8 Sep 2031 · NDA 021856 · FEBUXOSTAT
US 8,372,872, use patent
patent.txt lines 743, 745
Flags
use code U-1346
Product numbers
001, 002
8 Sep 2031 · NDA 021856 · FEBUXOSTAT
US 9,107,912, use patent
patent.txt lines 744, 746
Flags
use code U-1346
Product numbers
001, 002
11 Sep 2031 · NDA 022450 · ACETAMINOPHEN
US 9,399,012, use patent
patent.txt line 1,914
Flags
use code U-2261
Product numbers
001
11 Sep 2031 · NDA 022450 · ACETAMINOPHEN
US 9,399,012, use patent
patent.txt line 1,915
Flags
use code U-2262
Product numbers
001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,610,321, use patent
patent.txt line 9,309
Flags
use code U-1999
Product numbers
001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,610,321, use patent
patent.txt line 9,310
Flags
use code U-2230
Product numbers
001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,919,024, use patent
patent.txt line 9,312
Flags
use code U-1999
Product numbers
001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,919,024, use patent
patent.txt line 9,313
Flags
use code U-2230
Product numbers
001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,925,231, product patent
patent.txt line 9,314
Flags
product
Product numbers
001
20 Sep 2031 · NDA 212028 · LEMBOREXANT
US 8,268,848, substance and product and use patent
patent.txt lines 13,439, 13,443
Flags
substance product use code U-2791
Product numbers
001, 002
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,267, 9,271, 9,275, 9,280
Flags
substance product use code U-2135
Product numbers
001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,268, 9,272, 9,276, 9,281
Flags
substance product use code U-3242
Product numbers
001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,269, 9,273, 9,277, 9,282
Flags
substance product use code U-3265
Product numbers
001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,270, 9,274, 9,278, 9,283
Flags
substance product use code U-3546
Product numbers
001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt line 9,279
Flags
substance product use code U-1981
Product numbers
004
10 Oct 2031 · NDA 022156 · CLEVIDIPINE
US 10,010,537, product patent
patent.txt lines 1,123, 1,126, 1,129
Flags
product
Product numbers
001, 002, 003
10 Oct 2031 · NDA 022156 · CLEVIDIPINE
US 11,103,490, product patent
patent.txt lines 1,124, 1,127, 1,130
Flags
product
Product numbers
001, 002, 003
10 Oct 2031 · NDA 022156 · CLEVIDIPINE
US 8,658,676, product patent
patent.txt lines 1,125, 1,128, 1,131
Flags
product
Product numbers
001, 002, 003
14 Oct 2031 · NDA 022081 · AMBRISENTAN
US 9,549,926, use patent
patent.txt lines 1,042, 1,045
Flags
use code U-1965
Product numbers
001, 002
20 Oct 2031 · NDA 208623 · MIGALASTAT HYDROCHLORIDE
US RE48608, use patent
patent.txt line 8,993
Flags
use code U-2371
Product numbers
001
22 Oct 2031 · NDA 021355 · DROSPIRENONE; ESTRADIOL
US 8,906,890, product patent
patent.txt line 558
Flags
product
Product numbers
001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,189,849, substance patent
patent.txt line 15,633
Flags
substance
Product numbers
001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,189,850, product patent
patent.txt line 15,634
Flags
product
Product numbers
001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,927,120, product patent
patent.txt line 15,635
Flags
product
Product numbers
001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 11,040,042, product patent
patent.txt line 15,638
Flags
product
Product numbers
001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 8,598,197, substance and product patent
patent.txt line 15,645
Flags
substance product
Product numbers
001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 9,957,276, substance patent
patent.txt line 15,648
Flags
substance
Product numbers
001
27 Oct 2031 · NDA 215596 · MARIBAVIR
US 12,447,169, use patent
patent.txt line 17,475
Flags
use code U-4329
Product numbers
001
27 Oct 2031 · NDA 215596 · MARIBAVIR
US 12,661,368, use patent
patent.txt line 17,478
Flags
use code U-4572
Product numbers
001
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,748,573, use patent
patent.txt line 3,338
Flags
use code U-4345
Product numbers
001
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,748,573, use patent
patent.txt lines 3,336, 3,351
Flags
use code U-1515
Product numbers
001, 002
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,748,573, use patent
patent.txt lines 3,337, 3,352
Flags
use code U-1516
Product numbers
001, 002
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,802,628, product patent
patent.txt lines 3,340, 3,354
Flags
product
Product numbers
001, 002
2 Nov 2031 · NDA 207924 · BARICITINIB
US 11,806,555, use patent
patent.txt lines 7,475, 7,481, 7,487
Flags
use code U-3500
Product numbers
001, 002, 003
2 Nov 2031 · NDA 207924 · BARICITINIB
US 9,737,469, use patent
patent.txt lines 7,479, 7,485, 7,490
Flags
use code U-3500
Product numbers
001, 002, 003
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 10,478,502, product and use patent
patent.txt line 10,163
Flags
product use code U-2625
Product numbers
001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 11,839,656, use patent
patent.txt line 10,166
Flags
use code U-2625
Product numbers
001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 11,957,753, product patent
patent.txt line 10,167
Flags
product
Product numbers
001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 11,986,527, use patent
patent.txt line 10,168
Flags
use code U-2625
Product numbers
001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 12,076,403, product patent
patent.txt line 10,169
Flags
product
Product numbers
001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 8,809,307, product patent
patent.txt line 10,170
Flags
product
Product numbers
001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 10,478,502, product and use patent
patent.txt line 10,171
Flags
product use code U-2625
Product numbers
001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 11,839,656, use patent
patent.txt line 10,172
Flags
use code U-2625
Product numbers
001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 11,957,753, product patent
patent.txt line 10,173
Flags
product
Product numbers
001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 11,986,527, use patent
patent.txt line 10,174
Flags
use code U-2625
Product numbers
001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 12,076,403, product patent
patent.txt line 10,175
Flags
product
Product numbers
001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 8,809,307, product patent
patent.txt line 10,176
Flags
product
Product numbers
001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,052,334, use patent
patent.txt line 13,798
Flags
use code U-2968
Product numbers
001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,195,210, use patent
patent.txt line 13,799
Flags
use code U-2968
Product numbers
001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,342,800, use patent
patent.txt line 13,800
Flags
use code U-2968
Product numbers
001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,722,522, use patent
patent.txt line 13,802
Flags
use code U-2968
Product numbers
001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 9,737,547, use patent
patent.txt line 13,805
Flags
use code U-2968
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,193,732, substance and product patent
patent.txt line 9,711
Flags
substance product
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,721
Flags
use code U-1981
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,722
Flags
use code U-2355
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,723
Flags
use code U-2356
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,724
Flags
use code U-3265
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,725
Flags
use code U-3266
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,726
Flags
use code U-3975
Product numbers
001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,727
Flags
use code U-3999
Product numbers
001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,193,732, substance and product patent
patent.txt line 11,052
Flags
substance product
Product numbers
001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 11,058
Flags
use code U-2505
Product numbers
001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 11,059
Flags
use code U-3264
Product numbers
001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 11,060
Flags
use code U-3998
Product numbers
001
10 Nov 2031 · NDA 211765 · UBROGEPANT
US 9,499,545, substance and product and use patent
patent.txt lines 13,169, 13,181
Flags
substance product use code U-2718
Product numbers
001, 002
10 Nov 2031 · NDA 211765 · UBROGEPANT
US 9,833,448, use patent
patent.txt lines 13,170, 13,182
Flags
use code U-2718
Product numbers
001, 002
10 Nov 2031 · NDA 215206 · ATOGEPANT
US 9,499,545, substance and product and use patent
patent.txt lines 16,565, 16,572, 16,578
Flags
substance product use code U-3534
Product numbers
001, 002, 003
16 Nov 2031 · NDA 212327 · FEDRATINIB HYDROCHLORIDE
US 7,528,143, substance and product patent
patent.txt line 13,951
Flags
substance product
Product numbers
001
17 Nov 2031 · NDA 050808 · MINOCYCLINE HYDROCHLORIDE
US 9,192,615, product patent
patent.txt lines 2,166, 2,168
Flags
product
Product numbers
004, 005
21 Nov 2031 · NDA 208573 · VENETOCLAX
US 10,730,873, substance patent
patent.txt lines 8,860, 8,874, 8,888
Flags
substance
Product numbers
001, 002, 003
1 Dec 2031 · NDA 208552 · OXYMETAZOLINE HYDROCHLORIDE
US 8,883,838, product patent
patent.txt line 8,678
Flags
product
Product numbers
001
5 Dec 2031 · NDA 209637 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt lines 10,691, 10,709
Flags
substance product use code U-2202
Product numbers
001, 002
5 Dec 2031 · NDA 209637 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt lines 10,726, 10,761, 10,768, 10,777
Flags
substance product use code U-3355
Product numbers
003, 005, 006, 007
5 Dec 2031 · NDA 209637 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt line 10,744
Flags
substance product use code U-3469
Product numbers
004
5 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt lines 14,591, 14,606, 14,621, 14,631, 14,640, 14,649
Flags
substance product use code U-2628
Product numbers
001, 002, 003, 004, 005, 006
5 Dec 2031 · NDA 215256 · SEMAGLUTIDE
US 8,129,343, substance and product patent
patent.txt lines 16,608, 16,616, 16,624, 16,632, 16,642, 16,651, 16,663, 16,675, 16,687, 16,699, 16,711, 16,716
Flags
substance product
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 009, 010, 011, 012
5 Dec 2031 · NDA 218316 · SEMAGLUTIDE
US 8,129,343, substance and product patent
patent.txt lines 20,939, 20,947, 20,955, 20,964
Flags
substance product
Product numbers
001, 002, 003, 004
8 Dec 2031 · NDA 214787 · REMDESIVIR
US 11,492,353, substance patent
patent.txt lines 16,141, 16,175
Flags
substance
Product numbers
001, 002
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 10,086,047, product patent
patent.txt lines 14,579, 14,594, 14,609
Flags
product
Product numbers
001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 10,960,052, product patent
patent.txt lines 14,582, 14,597, 14,612
Flags
product
Product numbers
001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 11,382,957, product patent
patent.txt lines 14,584, 14,599, 14,614
Flags
product
Product numbers
001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 11,382,957, substance and product patent
patent.txt lines 14,626, 14,635, 14,644
Flags
substance product
Product numbers
004, 005, 006
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 9,278,123, product and use patent
patent.txt lines 14,593, 14,608, 14,623
Flags
product use code U-2628
Product numbers
001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 9,278,123, substance and product and use patent
patent.txt line 14,651
Flags
substance product use code U-2628
Product numbers
006
16 Dec 2031 · NDA 218316 · SEMAGLUTIDE
US 11,382,957, product patent
patent.txt lines 20,935, 20,943, 20,951, 20,960
Flags
product
Product numbers
001, 002, 003, 004
16 Dec 2031 · NDA 218316 · SEMAGLUTIDE
US 9,278,123, product and use patent
patent.txt lines 20,957, 20,966
Flags
product use code U-4389
Product numbers
003, 004
19 Dec 2031 · NDA 209803 · ERTUGLIFLOZIN
US 8,080,580, substance and product and use patent
patent.txt lines 10,800–10,801
Flags
substance product use code U-2214
Product numbers
001, 002
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 8,808,740, product and use patent
patent.txt lines 6,617, 6,636, 6,655, 6,674, 6,693, 6,712, 6,731
Flags
product use code U-1556
Product numbers
001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,572,779, product patent
patent.txt lines 6,627, 6,646, 6,665, 6,684, 6,703, 6,722, 6,741
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,750,703, product patent
patent.txt lines 6,628, 6,647, 6,666, 6,685, 6,704, 6,723, 6,742
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,861,584, product patent
patent.txt lines 6,632, 6,651, 6,670, 6,689, 6,708, 6,727, 6,746
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,872,837, product patent
patent.txt lines 6,633, 6,652, 6,671, 6,690, 6,709, 6,728, 6,747
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
28 Dec 2031 · NDA 022192 · ILOPERIDONE
US 9,074,254, use patent
patent.txt lines 1,153, 1,167, 1,181, 1,195, 1,209, 1,223, 1,237
Flags
use code U-1674
Product numbers
001, 002, 003, 004, 005, 006, 007

Pediatric exclusivity, as listed (67)

5 Jan 2031 · NDA 201292 · AFATINIB DIMALEATE
US 10,004,743 with pediatric exclusivity, as listed
patent.txt lines 2,398, 2,408, 2,418
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
1 Feb 2031 · NDA 207947 · SELEXIPAG
US 8,791,122 with pediatric exclusivity, as listed
patent.txt lines 7,700, 7,712, 7,724, 7,736, 7,748, 7,760, 7,772, 7,784, 7,796, 7,808
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 010, 011
1 Feb 2031 · NDA 214275 · SELEXIPAG
US 8,791,122 with pediatric exclusivity, as listed
patent.txt line 15,660
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Mar 2031 · NDA 204671 · SOFOSBUVIR
US 9,284,342 with pediatric exclusivity, as listed
patent.txt lines 4,959, 4,977
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Mar 2031 · NDA 202992 · TERIFLUNOMIDE
US 8,802,735 with pediatric exclusivity, as listed
patent.txt lines 3,590, 3,596
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
30 Mar 2031 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 10,610,489 with pediatric exclusivity, as listed
patent.txt lines 6,292, 6,323, 6,354, 6,383
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
4 Apr 2031 · NDA 206947 · LENVATINIB MESYLATE
US 12,508,313 with pediatric exclusivity, as listed
patent.txt lines 6,887, 6,908
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
11 Apr 2031 · NDA 204275 · FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US 8,746,242 with pediatric exclusivity, as listed
patent.txt lines 4,435, 4,445, 4,453
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
11 Apr 2031 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 8,746,242 with pediatric exclusivity, as listed
patent.txt lines 10,410, 10,417
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Apr 2031 · NDA 202806 · DABRAFENIB MESYLATE
US 8,703,781 with pediatric exclusivity, as listed
patent.txt lines 3,262, 3,286
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Apr 2031 · NDA 202806 · DABRAFENIB MESYLATE
US 8,952,018 with pediatric exclusivity, as listed
patent.txt lines 3,267, 3,291
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Apr 2031 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,703,781 with pediatric exclusivity, as listed
patent.txt lines 4,277, 4,297, 4,317
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
15 Apr 2031 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,952,018 with pediatric exclusivity, as listed
patent.txt lines 4,283, 4,303, 4,323
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
16 Apr 2031 · NDA 021936 · TIOTROPIUM BROMIDE
US 8,733,341 with pediatric exclusivity, as listed
patent.txt line 812
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
21 Apr 2031 · NDA 022145 · RALTEGRAVIR POTASSIUM
US 9,649,311 with pediatric exclusivity, as listed
patent.txt line 1,121
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
002
26 Apr 2031 · NDA 022249 · BENDAMUSTINE HYDROCHLORIDE
US 8,436,190 with pediatric exclusivity, as listed
patent.txt lines 1,361, 1,378
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
27 Apr 2031 · NDA 201023 · CABAZITAXEL
US 10,583,110 with pediatric exclusivity, as listed
patent.txt line 2,312
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
27 Apr 2031 · NDA 201023 · CABAZITAXEL
US 10,716,777 with pediatric exclusivity, as listed
patent.txt line 2,314
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
27 Apr 2031 · NDA 201023 · CABAZITAXEL
US 12,453,712 with pediatric exclusivity, as listed
patent.txt line 2,316
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
27 Apr 2031 · NDA 201023 · CABAZITAXEL
US 8,927,592 with pediatric exclusivity, as listed
patent.txt line 2,320
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
12 May 2031 · NDA 205649 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,616,028 with pediatric exclusivity, as listed
patent.txt lines 5,718, 5,728, 5,738, 5,748, 5,758
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
11 Jun 2031 · NDA 204671 · SOFOSBUVIR
US 8,618,076 with pediatric exclusivity, as listed
patent.txt lines 4,951, 4,969
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Jun 2031 · NDA 202324 · AXITINIB
US 8,791,140 with pediatric exclusivity, as listed
patent.txt lines 3,054, 3,063
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,291,904 with pediatric exclusivity, as listed
patent.txt lines 198, 220
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,573,209 with pediatric exclusivity, as listed
patent.txt lines 204, 226
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,573,210 with pediatric exclusivity, as listed
patent.txt lines 206, 228
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,776,794 with pediatric exclusivity, as listed
patent.txt lines 208, 230
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,776,795 with pediatric exclusivity, as listed
patent.txt lines 210, 232
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 9,265,911 with pediatric exclusivity, as listed
patent.txt line 238
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 9,295,802 with pediatric exclusivity, as listed
patent.txt line 242
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 9,408,993 with pediatric exclusivity, as listed
patent.txt line 244
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
003
20 Jul 2031 · NDA 022512 · DABIGATRAN ETEXILATE MESYLATE
US 9,034,822 with pediatric exclusivity, as listed
patent.txt lines 2,015, 2,019, 2,023
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
17 Aug 2031 · NDA 202811 · LINACLOTIDE
US 8,933,030 with pediatric exclusivity, as listed
patent.txt lines 3,341, 3,355, 3,369
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
24 Aug 2031 · NDA 202155 · APIXABAN
US 9,326,945 with pediatric exclusivity, as listed
patent.txt lines 2,787, 2,795, 2,799
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
5 Sep 2031 · NDA 201280 · LINAGLIPTIN
US 8,853,156 with pediatric exclusivity, as listed
patent.txt line 2,338
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Sep 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,415,355 with pediatric exclusivity, as listed
patent.txt line 9,698
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Sep 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,415,355 with pediatric exclusivity, as listed
patent.txt line 11,043
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Oct 2031 · NDA 208082 · DEUTETRABENAZINE
US 8,524,733 with pediatric exclusivity, as listed
patent.txt lines 8,132, 8,164, 8,196
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
3 Oct 2031 · NDA 216354 · DEUTETRABENAZINE
US 8,524,733 with pediatric exclusivity, as listed
patent.txt lines 18,549, 18,579, 18,609, 18,639, 18,669, 18,699, 18,729, 18,759
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006, 007, 008
20 Nov 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 10,758,543 with pediatric exclusivity, as listed
patent.txt line 16,737
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
20 Nov 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 10,869,870 with pediatric exclusivity, as listed
patent.txt line 16,739
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
20 Nov 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,219,624 with pediatric exclusivity, as listed
patent.txt line 16,742
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
23 Nov 2031 · NDA 200603 · LURASIDONE HYDROCHLORIDE
US 9,259,423 with pediatric exclusivity, as listed
patent.txt lines 2,249, 2,260, 2,271, 2,282, 2,293
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,004,746 with pediatric exclusivity, as listed
patent.txt lines 5,467, 5,566
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,016,435 with pediatric exclusivity, as listed
patent.txt lines 5,472, 5,571
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,478,439 with pediatric exclusivity, as listed
patent.txt lines 5,484, 5,583
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,751,342 with pediatric exclusivity, as listed
patent.txt lines 5,494, 5,593
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 8,999,999 with pediatric exclusivity, as listed
patent.txt lines 5,540, 5,637
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 9,125,889 with pediatric exclusivity, as listed
patent.txt lines 5,543, 5,641
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 9,801,881 with pediatric exclusivity, as listed
patent.txt lines 5,562, 5,659
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 9,801,883 with pediatric exclusivity, as listed
patent.txt lines 5,564, 5,661
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,004,746 with pediatric exclusivity, as listed
patent.txt lines 11,587, 11,693, 11,797, 11,901
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,016,435 with pediatric exclusivity, as listed
patent.txt lines 11,594, 11,700, 11,804, 11,908
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,478,439 with pediatric exclusivity, as listed
patent.txt lines 11,604, 11,710, 11,814, 11,918
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,653,696 with pediatric exclusivity, as listed
patent.txt line 11,927
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,751,342 with pediatric exclusivity, as listed
patent.txt lines 11,614, 11,720, 11,824, 11,931
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 8,754,090 with pediatric exclusivity, as listed
patent.txt line 11,971
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 8,999,999 with pediatric exclusivity, as listed
patent.txt lines 11,668, 11,772, 11,876, 11,985
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,125,889 with pediatric exclusivity, as listed
patent.txt lines 11,673, 11,777, 11,881, 11,990
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,801,881 with pediatric exclusivity, as listed
patent.txt lines 11,687, 11,791, 11,895, 12,003
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,801,883 with pediatric exclusivity, as listed
patent.txt lines 11,690, 11,794, 11,898, 12,006
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,814,721 with pediatric exclusivity, as listed
patent.txt line 12,009
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
004
7 Dec 2031 · NDA 021035 · LEVETIRACETAM
US 8,802,142 with pediatric exclusivity, as listed
patent.txt lines 399, 401, 403, 405
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
10 Dec 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,130,640 with pediatric exclusivity, as listed
patent.txt line 7,364
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
10 Dec 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 9,119,781 with pediatric exclusivity, as listed
patent.txt line 7,371
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
21 Dec 2031 · NDA 204026 · POMALIDOMIDE
US 8,828,427 with pediatric exclusivity, as listed
patent.txt lines 4,198, 4,204, 4,210, 4,216
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
30 Dec 2031 · NDA 204447 · VORTIOXETINE HYDROBROMIDE
US 8,722,684 with pediatric exclusivity, as listed
patent.txt lines 4,700, 4,720, 4,740, 4,760
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004

Non-patent exclusivity (28)

9 Feb 2031 · NDA 213976 · BUDESONIDE
ODE-466 exclusivity
exclusivity.txt line 1,285
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
23 Feb 2031 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
ODE-468 exclusivity
exclusivity.txt lines 862, 866
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
7 Mar 2031 · NDA 213217 · ZANUBRUTINIB
ODE-467 exclusivity
exclusivity.txt line 1,167
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
7 Mar 2031 · NDA 218785 · ZANUBRUTINIB
ODE* exclusivity
exclusivity.txt line 2,199
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
13 Mar 2031 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE-471 exclusivity
exclusivity.txt line 1,352
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
13 Mar 2031 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE* exclusivity
exclusivity.txt line 1,355
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
002
19 Mar 2031 · NDA 203469 · PONATINIB HYDROCHLORIDE
ODE-472 exclusivity
exclusivity.txt lines 324, 326, 328, 330
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004
26 Mar 2031 · NDA 203341 · BOSUTINIB MONOHYDRATE
PED exclusivity
exclusivity.txt lines 310, 314, 318
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
18 Apr 2031 · NDA 208434 · ALECTINIB HYDROCHLORIDE
ODE-477 exclusivity
exclusivity.txt line 708
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
23 Apr 2031 · NDA 208700 · LUTETIUM LU-177 DOTATATE
ODE-479 exclusivity
exclusivity.txt line 748
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
26 Apr 2031 · NDA 211675 · UPADACITINIB
ODE-481 exclusivity
exclusivity.txt lines 987, 992, 996
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
26 Apr 2031 · NDA 218347 · UPADACITINIB
ODE-481 exclusivity
exclusivity.txt line 2,151
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
29 May 2031 · NDA 213246 · SELPERCATINIB
ODE-484 exclusivity
exclusivity.txt lines 1,177, 1,199
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
29 May 2031 · NDA 213246 · SELPERCATINIB
ODE-485 exclusivity
exclusivity.txt lines 1,178, 1,200
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
29 May 2031 · NDA 213246 · SELPERCATINIB
ODE-487 exclusivity
exclusivity.txt lines 1,179, 1,201
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
8 Jun 2031 · NDA 207500 · ISAVUCONAZONIUM SULFATE
PED exclusivity
exclusivity.txt lines 598–599, 608–609
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002
8 Jun 2031 · NDA 207501 · ISAVUCONAZONIUM SULFATE
PED exclusivity
exclusivity.txt lines 619–620
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
21 Jun 2031 · NDA 211150 · PITOLISANT HYDROCHLORIDE
ODE-489 exclusivity
exclusivity.txt lines 935, 940
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
24 Jul 2031 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE-490 exclusivity
exclusivity.txt line 1,357
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
002
30 Aug 2031 · NDA 209939 · LETERMOVIR
ODE-495 exclusivity
exclusivity.txt lines 822, 828
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
30 Aug 2031 · NDA 209939 · LETERMOVIR
ODE-497 exclusivity
exclusivity.txt lines 823, 829
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
30 Aug 2031 · NDA 209940 · LETERMOVIR
ODE-495 exclusivity
exclusivity.txt lines 834, 840
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
30 Aug 2031 · NDA 209940 · LETERMOVIR
ODE-497 exclusivity
exclusivity.txt lines 835, 841
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
16 Oct 2031 · NDA 214755 · SODIUM OXYBATE
ODE-494 exclusivity
exclusivity.txt lines 1,372, 1,375, 1,378, 1,381
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004
23 Oct 2031 · NDA 208700 · LUTETIUM LU-177 DOTATATE
PED exclusivity
exclusivity.txt line 750
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
29 Oct 2031 · NDA 215358 · ASCIMINIB HYDROCHLORIDE
ODE-499 exclusivity
exclusivity.txt lines 1,541, 1,549
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
29 Oct 2031 · NDA 215358 · ASCIMINIB HYDROCHLORIDE
ODE-500 exclusivity
exclusivity.txt lines 1,542, 1,550
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
29 Nov 2031 · NDA 213246 · SELPERCATINIB
PED exclusivity
exclusivity.txt lines 1,185–1,187, 1,207–1,209
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002